Predominant Promotion by Tacrolimus of Chondrogenic Differentiation to Proliferating Chondrocytes
Tacrolimus (FK506) has been used as a therapeutic drug beneficial for the treatment of rheumatoid arthritis in humans.In this study, we investigated the WARNING SHOT CITRUS effects of FK506 on cellular differentiation in cultured chondrogenic cells.Culture with FK506 led to a significant and concentration-dependent increase in Alcian blue staining